In vitro evaluation of the metabolic enzymes and drug interaction potential of triapine

被引：0
|
作者：
Anand Joshi
Brian F. Kiesel
Nupur Chaphekar
Reyna Jones
Jianxia Guo
Charles A. Kunos
Sarah Taylor
Edward Chu
Raman Venkataramanan
Jan H. Beumer
机构：
[1] University of Pittsburgh,Department of Pharmaceutical Sciences, School of Pharmacy
[2] UPMC Hillman Cancer Center,Cancer Therapeutics Program
[3] National Cancer Institute,Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis
[4] University of Pittsburgh-Magee Women’s Hospital,Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Medicine
[5] University of Pittsburgh School of Medicine,Division of Hematology
[6] University of Pittsburgh,Oncology, Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 86卷
关键词：
Triapine; Metabolism; Drug–drug interaction; CYP450; Metabolic pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：633 / 640
页数：7
相关论文
共 50 条
  • [11] Metabolic Enzymes of Helminth Parasites: Potential as Drug Targets
    Timson, David J.
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2016, 17 (03) : 280 - 295
  • [12] Metabolic enzymes as potential drug targets in Plasmodium falciparum
    Subbayya, INS
    Ray, SS
    Balaram, P
    Balaram, H
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1997, 106 : 79 - 94
  • [13] In Vitro Assessment of the Drug-Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug Transporters
    Gopaul, V. Sashi
    Vildhede, Anna
    Andersson, Tommy B.
    Erlandsson, Fredrik
    Lee, Caroline A.
    Johansson, Susanne
    Hilgendorf, Constanze
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2021, 378 (02): : 108 - 123
  • [14] Interaction potential of the endothelin-A receptor antagonist atrasentan with drug transporters and drug-metabolising enzymes assessed in vitro
    Weiss, Johanna
    Haefeli, Walter Emil
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (04) : 1093 - 1098
  • [15] Interaction potential of the endothelin-A receptor antagonist atrasentan with drug transporters and drug-metabolising enzymes assessed in vitro
    Johanna Weiss
    Walter Emil Haefeli
    Cancer Chemotherapy and Pharmacology, 2011, 68
  • [16] In Vitro Drug-Drug Interaction Evaluation of GalNAc Conjugated siRNAs Against CYP450 Enzymes and Transporters
    Ramsden, Diane
    Wu, Jing-Tao
    Zerler, Brad
    Iqbal, Sajida
    Jiang, Jim
    Clausen, Valerie
    Aluri, Krishna
    Gu, Yongli
    Dennin, Sean
    Kim, Joohwan
    Chong, Saeho
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (10) : 1183 - 1194
  • [17] Evaluation of drug-drug interaction potential of beraprost sodium mediated by P450 in vitro
    Fukazawa, Tominaga
    Yajima, Kanako
    Miyamoto, Yohei
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2008, 128 (10): : 1459 - 1465
  • [18] Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
    Christian Zurth
    Mikko Koskinen
    Robert Fricke
    Olaf Prien
    Timo Korjamo
    Kristina Graudenz
    Karsten Denner
    Michaela Bairlein
    Clemens-Jeremias von Bühler
    Gary Wilkinson
    Hille Gieschen
    European Journal of Drug Metabolism and Pharmacokinetics, 2019, 44 : 747 - 759
  • [19] Maraviroc:: in vitro assessment of drug-drug interaction potential
    Hyland, Ruth
    Dickins, Maurice
    Collins, Claire
    Jones, Hannah
    Jones, Barry
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (04) : 498 - 507
  • [20] In vitro prediction of potential metabolic drug interactions for Seroquel
    Grimm, SW
    Stams, KR
    Bui, K
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 198 - 198
12345